Introduction: A limited subset of HIV-1 infected adult individuals typically after at least 2-3 years of chronic infection, develop broadly neutralizing antibodies (bnAbs), suggesting that highly ...

Immunotherapy. 2014;6(1):51-57. Broadly neutralizing antibodies have also been tested on maternal and infant HIV-1 variants, to determine their efficacy on mother to child transmission.

Antibodies mediate a broad array of non-neutralizing Fc-mediated functions against HIV-1 including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP).

The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...

Billionaire Elon Musk's plundering of the US Agency for International Development (USAID) is already proving devastating for ...

10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

Clinical trials testing efficacy of novel HIV treatments rely on analytical treatment interruption (ATI). Using data from 24 prospective studies, the authors here show that the virus becomes ...

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...

Janssen’s single-tablet regimen Symtuza has been approved last year by the European Commission for the treatment of HIV in the EU. Sanofi is also working on an antibody HIV treatment that can ...

Jan. 24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II ...

This method could provide constant, passive protection against viruses like COVID-19 and influenza. Scientists from the Swedish University of Agricultural Sciences (SLU) and the University of Tartu ...